CLASS II Drug recall · Reported 2 Oct 2013 · FDA Enforcement Report

Progesterone in Ethyl Oleate 50 mg per mL Injection vial recalled

Walgreens is recalling Progesterone in Ethyl Oleate 50 mg per mL Injection vial, Inject Intramuscularly as, distributed nationwide in the US. The recall was initiated on 23 Aug 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: P50EO07121390A, Exp 1/12/14
Quantity recalled298 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1063-2013
FDA event ID
66330
Recalling firm
Walgreens, Deerfield, IL
Classification
Class II
Status
Terminated
Recall initiated
23 Aug 2013
FDA classified
26 Sep 2013
Reported
2 Oct 2013
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Sterility

Timeline

23 Aug 2013Recall initiated by company
26 Sep 2013Classified by FDA+34 days
2 Oct 2013Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate sterile injection due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Walgreens Progesterone in Ethyl Oleate 50 mg per mL Injection, 10 mL vial, Inject 1 mL Intramuscularly as directed by physician, Walgreens Specialty Pharmacy, Fresco, TX.

Where it was distributed

Nationwide

Nationwide

Stores named: Walgreens

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate sterile injection due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.

Which lots are affected?

Lot #: P50EO07121390A, Exp 1/12/14

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Progesterone recalls

All 29